Key result
SBRT plus surgery achieves 4-year disease-free survival in metastatic pulmonary artery intimal sarcoma.
Why the study?
Pulmonary artery intimal sarcoma is a rare tumor with poor prognosis and diagnostic delays due to mimicking thromboembolic disease, with limited results from adjuvant therapies.
Case Report (n=1)
SBRT may be an effective alternative to metastasectomy for pulmonary artery intimal sarcoma with lung metastases, potentially delaying or omitting palliative chemotherapy.
Hypothesis-generating for SBRT in pulmonary artery intimal sarcoma with metastases; prospective studies required before practice change.
Pulmonary artery intimal sarcoma (PAIS) is a rare tumor with a very poor prognosis. Clinical and radiological findings usually mimic thromboembolic disease, leading to diagnostic delays. The treatment of choice is surgery, and adjuvant chemotherapy and radiotherapy have limited results. We report the case of a 48-year-old male patient, initially suspected with pulmonary thromboembolism. The angio-CT revealed a filling defect in the pulmonary artery trunk. The patient underwent surgery, resulting in with complete resection of the mass with a diagnosis of PAIS. The tumor progressed rapidly in the lung, requiring surgery of multiple lung metastases. The patient was treated with stereotactic body radiation therapy (SBRT) on two occasions for new pulmonary lesions. In the last followup (4 years after initial diagnosis), the patient was disease-free. In conclusion, SBRT proved to be an alternative treatment to metastasectomy, allowing palliative chemotherapy to be delayed or omitted, which may result in improved quality of life.
No takes yet. Share an insight, caveat, or question.
García-Cabezas et al. (2017) conducted a case report in Pulmonary artery intimal sarcoma (PAIS) (n=1). Stereotactic body radiation therapy (SBRT) and surgery was evaluated on Disease-free survival at last follow-up. Stereotactic body radiation therapy (SBRT) combined with surgery resulted in a 4-year disease-free survival in a 48-year-old male with pulmonary artery intimal sarcoma and lung metastases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: